| Literature DB >> 19500400 |
Jamil Bacha1, James S Brodie, Matthew W Loose.
Abstract
BACKGROUND: Biological processes are regulated by complex interactions between transcription factors and signalling molecules, collectively described as Genetic Regulatory Networks (GRNs). The characterisation of these networks to reveal regulatory mechanisms is a long-term goal of many laboratories. However compiling, visualising and interacting with such networks is non-trivial. Current tools and databases typically focus on GRNs within simple, single celled organisms. However, data is available within the literature describing regulatory interactions in multi-cellular organisms, although not in any systematic form. This is particularly true within the field of developmental biology, where regulatory interactions should also be tagged with information about the time and anatomical location of development in which they occur. DESCRIPTION: We have developed myGRN (http://www.myGRN.org), a web application for storing and interrogating interaction data, with an emphasis on developmental processes. Users can submit interaction and gene expression data, either curated from published sources or derived from their own unpublished data. All interactions associated with publications are publicly visible, and unpublished interactions can only be shared between collaborating labs prior to publication. Users can group interactions into discrete networks based on specific biological processes. Various filters allow dynamic production of network diagrams based on a range of information including tissue location, developmental stage or basic topology. Individual networks can be viewed using myGRV, a tool focused on displaying developmental networks, or exported in a range of formats compatible with third party tools. Networks can also be analysed for the presence of common network motifs. We demonstrate the capabilities of myGRN using a network of zebrafish interactions integrated with expression data from the zebrafish database, ZFIN.Entities:
Mesh:
Year: 2009 PMID: 19500400 PMCID: PMC2702357 DOI: 10.1186/1471-213X-9-33
Source DB: PubMed Journal: BMC Dev Biol ISSN: 1471-213X Impact factor: 1.978
Figure 1Structure and utility of myGRN. The myGRN database is composed of genes and the interactions between them. Genes themselves are stored with Entrez IDs, and users can add expression data tagged with experimental metadata. Interactions are directed links between the genes in the database, and are tagged with metadata detailing the experiments and publications supporting the interaction. Networks are custom groups of genes and interactions generated by users, either by adding interactions individually or using the populate tools. Once a network is assembled, it can be analysed using the network parser, which applies a series of filters to generate a subset of the network. This can then be visualised directly in myGRV, analysed for network motifs in mFinder, or exported in a range of exchange formats.
Interaction evidence types supported by myGRN
| Mined from Literature | Inference of an interaction from | 0 |
| Transient transfection | Perturbation of expression of a reporter under control of the downstream gene promoter on disruption of upstream gene expression | 10 |
| Stable transgenic line | Perturbation of expression of a reporter under control of the downstream gene promoter on disruption of upstream gene expression | 10 |
| Protein synthesis inhibition | Demonstration of a direct interaction by inhibition of intermediate protein production using cyclohexamide or other inhibitors. | 50 |
| Prediction of a binding site for the upstream gene product in the downstream gene promoter using in silico methods. | 2 | |
| Elecrophoretic Mobility Shift Assay (EMSA) | EMSA showing direct binding between the upstream gene product and a fragment of the downstream gene promoter in vitro. | 25 |
| DNase Footprinting | Protection of a putative binding site in radiolabelled DNA containing the downstream gene promoter by the upstream gene product. | 25 |
| ChIP-on-chip | Chromatin Immunoprecipitation using antibody for the upstream gene, and analysis of the binding site locations on a microarray. | 25 |
| Stable transgenic reporter | Transgenic organism carrying a reporter gene under the control of the promoter of the gene of interest. | 25 |
| Transient transgenic reporter | Transient transfection of a construct carrying a reporter gene under the control of the promoter of the gene of interest. | 25 |
| SAGE | Detection of a sequence tag from an mRNA in a Serial Analysis of Gene Expression experiment. | 10 |
| RT-PCR | Measurement of mRNA by Reverse-Transcription Polymerase Chain Reaction. | 10 |
| Primer extension | Extension of a gene-specific primer using an mRNA template. | 10 |
| Nuclease protection | Measurement of mRNA by hybridization with an antisense probe followed by ribonuclease digestion of unbound RNA. | 10 |
| Northern Blot | Measurement of mRNA by northern blot. | 10 |
| Measurement of mRNA by in-situ hybridization. | 25 | |
| cDNA Library | Isolation of a gene from a cDNA library. | 10 |
| Array | Measurement of mRNA on an expression DNA microarray. | 10 |
| Western blot | Measurement of protein by western blot. | 10 |
| Mass Spectrometry | Detection of protein from cell or tissue extract using mass spectrometry. | 10 |
| Immunohistochemistry/immunocytochemistry | Measurement of protein by antibody staining in tissue slices or cultured cells. | 25 |
| Mutation of binding site | Site-directed mutagenesis of a known binding site of the upstream gene in the downstream gene's promoter leads to a decrease in activity of a reporter gene | 25 |
| Inference of an interaction from mathematical modelling of experimental data such as microarray time course. | 2 | |
| Transient transgenic | Transient transfection of a DNA construct containing the upstream gene, controlled by a constitutive or inducible promoter. | 10 |
| Stable transgenic | Stable transgenic cell or organism line containing the upstream gene controlled by a constitutive or inducible promoter. | 10 |
| RNA-based overexpression | Introduction of synthetic or purified mRNA of upstream gene into target cells or tissues. | 10 |
| Protein-based overexpression | Introduction of synthetic or purified protein product of upstream gene to target cells or tissues. | 10 |
| Transgenic knock-out | Stable transgenic cell or organism line with the upstream gene knocked-out either functionally or by expression. | 25 |
| RNAi | RNA interference-based knock-down or silencing of the upstream gene. | 25 |
| Morpholino | Morpholino-based inhibition of translation of the upstream gene mRNA. | 25 |
| Molecular Inhibitor | Use of an inhibitor molecule to reduce or eliminate the function of the upstream gene product. | 10 |
| Dominant-negative protein expression | Insertion of a dominant-negative version of an upstream regulator into a system reduces or eliminates expression of the target gene. | 10 |
There are 31 evidence types divided into three categories. Binding site evidence demonstrates a molecular interaction between the upstream gene product and the promoter of the downstream gene. Expression evidence shows that the interacting genes are co-expressed (activators) or inversely expressed (repressors) in a given tissue. Perturbation evidence shows that changes to the expression of the upstream gene lead to perturbed expression of the downstream gene. We have given each experimental evidence type one of four possible scores (50 – conclusive, 25 – strongly indicative, 10 – indicative or 2 – suggestive) reflecting how well it supports the appropriate category. Interaction evidence that is extracted from the literature with an NLP algorithm is not placed into any of these classes and does not contribute to the scoring of an interaction.
Figure 2Zebrafish development networks according to gene expression. (A) The complete set of Zebrafish interactions currently stored within myGRN. (B) A subset of genes from A that are expressed in the liver, and the interactions between them. (C) Expansion of B to include all interaction partners, regardless of expression location. Orange coloured genes are present in (B), yellow genes are expressed in liver but do not interact with other liver expressed genes, blue genes are not expressed in liver. These networks were exported from myGRN as graphML and visualised using the yEd Graph Editor . Different node shapes represent gene types: triangle = signal (ligand), rectangle = transcription factor, trapezoid = receptor, circle = terminal marker. Line styles represent interaction types: solid=direct, dashed = indirect, black arrow = activation, red arrow = repression, grey diamond = unknown.
Figure 3Layout methods in myGRV. The same network as Figure 2B, but viewed using myGRV. (A) shows a hierarchical layout, (B) shows a force-spring layout and (C) shows the layout in spatio-temporal view. Here genes are positioned according to the tissues in which they are expressed. (D) shows the same network as (A). In this case FoxA2 has been selected and (Di) highlights upstream interactors, (Dii) highlights genes immediately connected to the selected gene and (Diii) only highlights downstream targets. (E) shows an example of browsing the network detail via the myGRV interface. The key shows how different gene types and interactions are represented within myGRV.
Figure 4Motif detection in myGRV. myGRV provides basic motif detection algorithms. In this example, the same liver derived network is analysed for single-input, multi-component and feed-forward loops motifs. In the case of single-input and feed-forward loop motifs, myGRN highlights genes by altering the node size. The originating gene in the single input motifs is larger than its targets, the upstream genes in the feed-forward loop are larger than their targets.